Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

June 8, 2020

Navigating Kidney Cancer Treatment During COVID-19

Author(s):

Kidney Cancer Association

Getting kidney cancer treatment during the COVID-19 pandemic.

Mike Kelly, 67, was diagnosed with stage IV clear cell renal cell carcinoma (RCC) last fall and had a nephrectomy to remove his left kidney at MD Anderson Cancer Center (MDACC) in Houston, Texas soon after. Kelly also began participating in a clinical trial early in 2020 for which he takes the tyrosine kinase inhibitor Cabometyx® (cabozantinib).

Already attentive to news about the novel coronavirus COVID-19 and his increased risk as someone over age 60 with cancer and a compromised immune system, Kelly began modifying his behavior even before Houston residents were officially advised to distance from each other. He stopped going to his office where he works as an attorney, opting to work from home, and eventually moved from his home into the home where his daughter, son-in-law, and three grandchildren live.

In mid-March, his visits to MDACC changed as well and became more regimented as the hospital put protective protocols in place.

“I wore gloves and a plain mask, like you’d buy at the hardware store,” Kelly said about one of his previous visits to MDACC. “Before, only the people who might have a cold were wearing masks but since coronavirus, everyone is wearing a mask”

Entry into the hospital required a questionnaire about travel and contact with others who may have coronavirus, Kelly said, as well as checking body temperature. He found waiting rooms were kept sparsely populated to maintain distance. There were always people ready to direct him to his intended destination. Kelly observed staff frequently changed gloves and wiped down surfaces with cleaners, including things like computers and keyboards, which he didn’t recall them doing previously.

“It was orderly and methodical,” he said. “I was paying attention to things like distancing and handling things. People must be dealing with some level of stress because of being exposed to other people but they didn’t show it. They were polite and caring and I felt a keen appreciation for them being there.”

Because Kelly is participating in a clinical trial, he needs CAT scans and to have blood drawn on a regular schedule. His care team try to stack such appointments to minimize Kelly’s hospital visits. Even for general appointments, things like checking temperature or blood pressure still require close contact.

“I felt ok,” Kelly said about such contact. “[People] gave no impression that I was not to be treated well and well cared for. They were not cavalier… they did what they had to do and they didn’t linger.”

Speaking with his oncologist, Dr. Nizar Tannir at MDACC, about how he is doing and how the clinical trial is going is a little different when done from some distance across an exam room, Kelly said, but he is still generous with his time.

And through these new conditions and protocols, Kelly and his care team still need to manage his cancer. That meant adjusting the cabozantinib dose from 60 mg to 40 mg to bring the fatigue, diarrhea, dry skin, and a few other side effects to manageable levels. That meant scheduling a telephone appointment with a nutritionist to adjust Kelly’s diet based on his treatment and single kidney. And continued communication will be important to make sure Kelly can continue to get effective treatment and manage his energy in order to spend time with his family.

“Since I’ve had more energy, I’ve cooked meals for everyone and spent more time playing around with my grandchildren [who are 4 years, 2 years, and 6 months old],” Kelly said. “They’re big puzzle builders, they read stories, we’ve gone on a few walks… We went on a walk to a little bridge near the house that’s green and has trees. Today we saw five turtles and one was really large! The 6-month-old doesn’t delight in the turtles, but the two older girls do.”

The presence of coronavirus may have very practical impacts for cancer care, but Kelly said it also heightened his awareness of others in specific ways too.

“Certainly, there’s a sense of care for the people impacted directly by the illness, or who have economic issues, or who are separated from family. Just like everybody else, I’m concern about getting through this and recuperating with minimum loss of life and illness and difficulty. There’s a lot of sacrifices, especially from our caregivers who expose themselves to even more risk. So I try to thank everybody.”

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with black hair.
Investigating the Addition of Surgery to ICI Therapy in Kidney Cancer
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Raising Awareness for Kidney Cancer and the Challenges Patients Face
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care
Image of man wearing baseball cap backwards.
A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Investigating Quality of Life and Treatment Adherence in Kidney Cancer
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Better Understanding Genetic Mutations Influence in Cancer Care
Image of doctor with brown hair.
COSMIC-313 Trial Lead Breaks Down Treatment Intensification in RCC
Image of man with black hair.
Personalized Medicine Makes Strides Across the GU Oncology Treatment Space
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma
Related Content
Advertisement
Blocking serotonin transporters with SSRIs enhanced immunotherapy response in mouse and human tumor models: © stock.adobe.com.
May 30th 2025

Antidepressants May Boost Antitumor Immunity

Spencer Feldman
Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse and human tumor models.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
From left: Carolyn M. Williams, CPCS, and Susan Rux, PH.D., D.N.P., RN, ACNS-BC, CENP, CNE, CPCC, FACHE, LNCC, NEA-BC, NPD-BC, OCN
May 12th 2025

Inspirational Leader Shines Her Light Outward to Others

Carolyn M. Williams, CPCS
Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Carmela Cuccurullo, AGPCNP-BC, OCN
May 9th 2025

Unmatched Energy, Every Single Day

Carmela Cuccurullo, AGPCNP-BC, OCN
For the past 2 years, I have worked alongside Carmela Cuccurullo, NP.
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting: ©  stock.adobe.com.
April 18th 2025

Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma

Alex Biese
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
Related Content
Kidney CancerKidney Cancer Association
Kidney Cancer
|
Kidney Cancer Association
Advertisement
Blocking serotonin transporters with SSRIs enhanced immunotherapy response in mouse and human tumor models: © stock.adobe.com.
May 30th 2025

Antidepressants May Boost Antitumor Immunity

Spencer Feldman
Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse and human tumor models.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
From left: Carolyn M. Williams, CPCS, and Susan Rux, PH.D., D.N.P., RN, ACNS-BC, CENP, CNE, CPCC, FACHE, LNCC, NEA-BC, NPD-BC, OCN
May 12th 2025

Inspirational Leader Shines Her Light Outward to Others

Carolyn M. Williams, CPCS
Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Carmela Cuccurullo, AGPCNP-BC, OCN
May 9th 2025

Unmatched Energy, Every Single Day

Carmela Cuccurullo, AGPCNP-BC, OCN
For the past 2 years, I have worked alongside Carmela Cuccurullo, NP.
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting: ©  stock.adobe.com.
April 18th 2025

Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma

Alex Biese
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
Advertisement
Advertisement
Advertisement
x
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.